NASDAQ: MRNA   $0.00 VOL:   $0.00
Moderna logo

Scientific & Medical Meetings

Featured Presentation

April 20, 2026

AACR 2026 (mRNA-4359 First-Line metastatic melanoma Phase 1/2 data)

Archived Presentations

Share by: